- £647.27m
- £809.59m
- €1.69bn
- 65
- 49
- 78
- 73
Annual income statement for C&C, fiscal year end - February 28th, EUR millions except per share, conversion factor applied.
2019 February 28th | 2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,575 | 1,719 | 737 | 1,438 | 1,689 |
| Cost of Revenue | |||||
| Gross Profit | 507 | 437 | 168 | 332 | 401 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,478 | 1,689 | 824 | 1,382 | 1,606 |
| Operating Profit | 96.7 | 30.7 | -86.9 | 56.5 | 83.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 81.8 | 11.6 | -121 | 45.7 | 65.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 72.1 | 9.1 | -105 | 37.1 | 51.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 72.3 | 9.1 | -105 | 37.1 | 51.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 72.3 | 9.1 | -105 | 37.1 | 51.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.245 | 0.328 | -0.218 | 0.022 | 0.135 |
| Dividends per Share |